title: Should INTERACT 2 results modify our management of acute spontaneous intra-cerebral haemorrhages?
authors.affiliation: EA 1046, Department of neurology, Stroke centre, Roger-Salengro hospital, Lille University Hospital, rue Émile-Laine, 59037 Lille, France.
authors.forename: C
authors.initials: C
authors.lastname: Cordonnier
authors.forename: D
authors.initials: D
authors.lastname: Leys
mesh_terms: D000208:Acute Disease; D061605:Administration, Intravenous; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000628:therapy*; D003422:Critical Care / Q000379:methods; D019317:Evidence-Based Medicine / Q000592:standards / Q000639:trends; D006801:Humans; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
chemical_list: D000959:Antihypertensive Agents; D010959:Tissue Plasminogen Activator; D001241:Aspirin